Lucas Wong, M.D.

Primary Office

Temple Clinic
254-724-1713

Lucas Wong, M.D.

  • Principal Investigator, Community Clinical Oncology Program
  • Co-Director, Gastrointestinal Cancer Program


Gastrointestinal Cancer, Hematology and Oncology

Faculty Rank - Texas A&M Health Science Center College of Medicine

Associate Professor of Medicine

Education

  • University of Texas Health Science Center at San Antonio, TX, M.D., 1988
  • University of Texas at Austin, TX, B.S., 1984

Specialty Training

  • Hematology/Oncology Fellowship, Arizona Cancer Center, University of Arizona Health Science Center, Tucson, AZ, 1991-1994 
  • Internal Medicine Internship and Residency, University of North Carolina Hospitals, Chapel Hill, NC, 1988-1991

Scott & White Appointment

July 18, 1994

Board Certification

American Board of Internal Medicine, Medical Oncology

Publications and Research

  • Mishra R, Barthwal MK, Sondarva G, Rana B, Wong L, Chatterjee M, Woodgett JR, Rana A.
    Glycogen Synthase Kinase-3 beta Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase-3. J Biol Chem. 2007 Oct 19;282(42):30393-405. Epub 2007
  • Ochs AM, Wong L, Kakani V, Neerukonda S, Gorske J, Rao A, Riggs M, Ward H, Keville L.
    Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival. Clin.Colorectal Cancer 2004; 4[4]:262-267.  
  • Sharma C, Pradeep A, Wong L, Rana A, Rana B.
    PPARgamma activation can regulate beta -catenin levels via a proteasome mediated and APC independent pathway. Journal of Biological Chemistry 2004.  
  • Rinehart J, Keville L, Neidhart J, Wong L, DiNunno L, Kinney P, Aberle M, Tadlock L, Cloud G.
    Hematopoietic Protection by Dexamethasone or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients Treated With Carboplatin and Ifosfamide. American Journal of Clinical Oncology 2003; 26[5]:448-458. 
  • Cool RM, Herrington JD, Wong L.
    Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide. Pharmacotherapy 2002; 22[9]:1200-1204. 
  • Wong L, Taylor CW, Radwanski E, Hersh EM, Salmon SE.
    Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor. J.Immunother.Emphasis.Tumor Immunol. 1995; 18[1]:57-65.

Professional Activities

  • Southwest Oncology Group Investigator
  • Member of Gastrointestinal Cancer Committee
  • National Surgical Adjuvant Breast and Bowel Project Investigator
  • Member of the Colorectal Cancer Committee

Awards

Upjohn Company Outstanding Oncology Fellow, 1994


Scott & White • 2401 S. 31st St. • Temple, TX  76508
• 254-724-2111 • 800-792-3710 • 254-724-3038 (TTY)
©2010 Scott & White. All rights reserved.